Patient and Health Care Professional Perceptions of the Experience and Impact of Symptoms of Moderate-to-Severe Crohn’s Disease in US and Europe: Results from the Cross-Sectional CONFIDE Study
Digestive Diseases and Sciences · 2024-07 · 69 (7) · 2333-2344
DOI: 10.1007/s10620-024-08434-5 ↗Kurz gefasst
Querschnittstudie in der Zeitschrift Digestive Diseases and Sciences, online erschienen am 03.05.2024. Verfasst von Stefan Schreiber und 12 weiteren Autor:innen. Beteiligte Einrichtung: University Hospital Schleswig-Holstein, Keil University, Kiel, Germany. s.schreiber@mucosa.de. Hauptthemen laut MEDLINE: Crohn Disease. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Eli Lilly and Company, Christian-Albrechts-Universität zu Kiel.
Abstract (Originalsprache)
BACKGROUND: Crohn's disease (CD) significantly affects patients' health-related quality of life and well-being. AIMS: Communicating Needs and Features of IBD Experiences (CONFIDE) survey explores the experience and impact of moderate-to-severe CD symptoms on patients' lives and identifies communication gaps between patients and health care professionals (HCPs). METHODS: Online, quantitative, cross-sectional surveys of patients, and HCPs were conducted in the United States (US), Europe (France, Germany, Italy, Spain, United Kingdom), and Japan. Criteria based on previous treatment, steroid use, and/or hospitalization defined moderate-to-severe CD. US and Europe data are presented as descriptive statistics. RESULTS: Surveys were completed by 215 US and 547 European patients and 200 US and 503 European HCPs. In both patient groups, top three symptoms currently (past month) experienced were diarrhea, bowel urgency, and increased stool frequency, with more than one-third patients wearing diaper/pad/protection at least once a week in past 3 months due to fear of bowel urgency-related accidents. HCPs ranked diarrhea, blood in stool, and increased stool frequency as the most common symptoms. Although 34.0% US and 27.2% European HCPs ranked bowel urgency among the top five symptoms affecting patient lives, only 12.0% US and 10.9% European HCPs ranked it among top three most impactful symptoms on treatment decisions. CONCLUSION: Bowel urgency is common and impactful among patients with CD in the US and Europe. Differences in patient and HCP perceptions of experiences and impacts of bowel urgency exist, with HCPs underestimating its burden. Proactive communication between HCPs and patients in clinical settings is crucial for improving health outcomes in patients with CD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- University Hospital Schleswig-Holstein, Keil University, Kiel, Germany. s.schreiber@mucosa.de.
- Eli Lilly and Company, Indianapolis, USA.
- University of Calgary, Calgary, Canada.
- University of Chicago Medicine, Chicago, USA.
- University of Oxford, Oxford, UK.
- Kitasato University, Tokyo, Japan.
Förderung
- Eli Lilly and Company
- Christian-Albrechts-Universität zu Kiel
Zitieren
APA
Schreiber, S., Hunter Gibble, T., Panaccione, R., Rubin, D. T., Travis, S., Hibi, T., Potts Bleakman, A., Panni, T., Favia, A. D., Kayhan, C., Atkinson, C., Saxena, S., & Dubinsky, M. C. (2024). Patient and Health Care Professional Perceptions of the Experience and Impact of Symptoms of Moderate-to-Severe Crohn’s Disease in US and Europe: Results from the Cross-Sectional CONFIDE Study. Digestive Diseases and Sciences, 69(7), 2333-2344. https://doi.org/10.1007/s10620-024-08434-5
Vancouver
Schreiber S, Hunter Gibble T, Panaccione R, Rubin DT, Travis S, Hibi T, et al. Patient and Health Care Professional Perceptions of the Experience and Impact of Symptoms of Moderate-to-Severe Crohn’s Disease in US and Europe: Results from the Cross-Sectional CONFIDE Study. Digestive Diseases and Sciences. 2024;69(7):2333-2344. doi:10.1007/s10620-024-08434-5
BibTeX
@article{Schreiber2024,
author = {Schreiber, Stefan and Hunter Gibble, Theresa and Panaccione, Remo and Rubin, David T and Travis, Simon and Hibi, Toshifumi and Potts Bleakman, Alison and Panni, Tommaso and Favia, Angelo D and Kayhan, Cem and Atkinson, Christian and Saxena, Sonal and Dubinsky, Marla C},
title = {Patient and Health Care Professional Perceptions of the Experience and Impact of Symptoms of Moderate-to-Severe Crohn’s Disease in US and Europe: Results from the Cross-Sectional CONFIDE Study},
journal = {Digestive Diseases and Sciences},
year = {2024},
volume = {69},
number = {7},
pages = {2333--2344},
doi = {10.1007/s10620-024-08434-5}
}
EUVIMED